Could poor adherence to GLP-1 drugs among those using it for weight loss (30% stop within four weeks without achieving clinically meaningful weight loss2) be explained, in part, by a user experience that does not cater to the specific needs of this population
This looks like incentive-aligned behavior, not drama, said Kearney partner Todd Huseby
Clinically overt HT affects approximately 0.12% of the population, while the subclinical form is more prevalent, affecting 1015%
Klein S, Gastaldelli A, Yki-Jarvinen H, Scherer PE (2022) Why does obesity cause diabetes
What matters far more than which medication you choose is how you use it
Causes: The cause of oral melanoma or melanoma of any mucosal surface remains unknown, and the incidence has remained stable for more than 25 years